PCR-based analysis of PD-L1 RNA expression in lung cancer: comparison with commonly used immunohistochemical assays-Reference-Cited by-同舟云学术

PCR-based analysis of PD-L1 RNA expression in lung cancer: comparison with commonly used immunohistochemical assays

Published:2022-08 Issue: Volume:59 Page:151968
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Venina Aigul R.,Ivantsov Alexandr O.,Iyevleva Aglaya G.^ORCID,Kuligina Ekaterina Sh.,Preobrazhenskaya Elena V.,Yurlov Dmitry O.,Rawlinson Karen Eleanor,Kosmin Artem V.,Savelov Nikita A.,Raskin Grigory A.,Imyanitov Evgeny N.

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference31 articles.

1. Putting the immunologic brakes on cancer;Wolchok;Cell,2018

2. Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC;Camidge;Nat Rev Clin Oncol,2019

3. Translation of cancer immunotherapy from the bench to the bedside;Guo;Adv Cancer Res,2019

4. The pro-tumorigenic host response to cancer therapies;Shaked;Nat Rev Cancer,2019

5. Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC);Bodor;Cancer,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of molecular diagnostics for lung cancer;Exploration of Targeted Anti-tumor Therapy;2024-06-27

2. Plasma cell-free RNA PD-L1 or tissue PD-L1 protein expression and outcomes with first-line immunotherapy in metastatic non-small cell lung cancer;The Journal of Liquid Biopsy;2024-03

3. Hybridization chain reaction assisted terahertz metamaterial biosensor for highly sensitive detection of microRNAs;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-02

4. Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis;Frontiers in Oncology;2024-01-22

5. Heterogeneity in PD-L1 expression in MAML2-rearranged mucoepidermoid carcinoma;Pathology - Research and Practice;2024-01